Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
BioSphere Medical developed and commercialized bioengineered polymer bead devices ("microspheres") used in minimally invasive procedures such as tumor localization for breast cancer and uterine fibroid embolization. Their Embosphere Microspheres were FDA-cleared for use in various interventional radiology applications. The company pioneered wire-free tumor localization systems and accelerated partial breast irradiation technologies before being acquired.\n\nNo current clinical results as the company has been acquired.\n\n[1][2][3]
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on BioSphere Medical.